Lachman Consultants Blog Promotional Guidance for Biosimilars Tiptoes Around Interchangeability

The newly issued revised and finalized "Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers: Guidance for Industry" (here) does not differ much from the previous draft guidance of the same title issued on April 25, 2024 (89 FR 31757). The final guidance was revised to incorporate comments [...]The post Promotional Guidance for Biosimilars Tiptoes Around Interchangeability appeared first on Lachman Consultant Services, Inc..